Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 128.00 | 138.25 | 0.9259 | 0.7520 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 92.36 | 185.00 | 138.25 | 1.3382 | 2.2994 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 184.00 | 138.25 | 1.3309 | 2.2688 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 92.36 | 164.00 | 138.25 | 1.1863 | 1.6823 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 156.25 | 92.36 | 80.00 | 138.25 | 0.5787 | -0.2188 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 156.25 | 92.36 | 165.00 | 138.25 | 1.1935 | 1.7105 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 156.25 | 92.36 | 75.00 | 138.25 | 0.5425 | -0.3008 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 134.00 | 138.25 | 0.9693 | 0.8955 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 143.00 | 138.25 | 1.0344 | 1.1195 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 92.36 | 111.00 | 138.25 | 0.8029 | 0.3715 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 155.00 | 138.25 | 1.1212 | 1.4344 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 140.00 | 138.25 | 1.0127 | 1.0437 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 156.25 | 92.36 | 111.00 | 138.25 | 0.8029 | 0.3715 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 105.00 | 138.25 | 0.7595 | 0.2465 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 92.36 | 117.00 | 138.25 | 0.8463 | 0.5013 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 96.00 | 138.25 | 0.6944 | 0.0686 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 156.25 | 92.36 | 155.00 | 138.25 | 1.1212 | 1.4344 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 206.00 | 138.25 | 1.4901 | 2.9691 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 156.25 | 92.36 | 146.00 | 138.25 | 1.0561 | 1.1965 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 92.36 | 102.00 | 138.25 | 0.7378 | 0.1860 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 156.25 | 92.36 | 111.00 | 138.25 | 0.8029 | 0.3715 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 232.00 | 138.25 | 1.6781 | 3.8686 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 251.00 | 138.25 | 1.8156 | 4.5738 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 92.36 | 186.00 | 138.25 | 1.3454 | 2.3301 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 156.25 | 92.36 | 91.00 | 138.25 | 0.6582 | -0.0252 |